(2025). Corrigendum: Synergistic anti-cancer effects of silibinin-etoposide combination against human breast carsinoma MCF-7 and MDA-MB-231 cell lines. Iranian Journal of Basic Medical Sciences, 28(12), -. doi: 10.22038/ijbms.2025.26928
MLA
. "Corrigendum: Synergistic anti-cancer effects of silibinin-etoposide combination against human breast carsinoma MCF-7 and MDA-MB-231 cell lines", Iranian Journal of Basic Medical Sciences, 28, 12, 2025, -. doi: 10.22038/ijbms.2025.26928
HARVARD
(2025). 'Corrigendum: Synergistic anti-cancer effects of silibinin-etoposide combination against human breast carsinoma MCF-7 and MDA-MB-231 cell lines', Iranian Journal of Basic Medical Sciences, 28(12), pp. -. doi: 10.22038/ijbms.2025.26928
CHICAGO
, "Corrigendum: Synergistic anti-cancer effects of silibinin-etoposide combination against human breast carsinoma MCF-7 and MDA-MB-231 cell lines," Iranian Journal of Basic Medical Sciences, 28 12 (2025): -, doi: 10.22038/ijbms.2025.26928
VANCOUVER
Corrigendum: Synergistic anti-cancer effects of silibinin-etoposide combination against human breast carsinoma MCF-7 and MDA-MB-231 cell lines. Iranian Journal of Basic Medical Sciences, 2025; 28(12): -. doi: 10.22038/ijbms.2025.26928
)